1. Home
  2. EVOK vs LCFY Comparison

EVOK vs LCFY Comparison

Compare EVOK & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$10.97

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Logo Locafy Limited

LCFY

Locafy Limited

HOLD

Current Price

$3.93

Market Cap

9.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVOK
LCFY
Founded
2007
2009
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
9.2M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
EVOK
LCFY
Price
$10.97
$3.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.4K
18.3K
Earning Date
11-13-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,424,652.00
$2,099,713.00
Revenue This Year
$58.96
N/A
Revenue Next Year
$57.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
67.40
N/A
52 Week Low
$1.94
$2.51
52 Week High
$10.99
$13.98

Technical Indicators

Market Signals
Indicator
EVOK
LCFY
Relative Strength Index (RSI) 84.66 51.77
Support Level $10.66 $3.70
Resistance Level $10.75 $4.03
Average True Range (ATR) 0.05 0.24
MACD -0.19 0.11
Stochastic Oscillator 87.50 89.54

Price Performance

Historical Comparison
EVOK
LCFY

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: